Please select the option that best describes you:

How are you approaching patients with Stage IV EGFR NSCLC who progress on first line TKI and are found to have retained EGFR mutation as well as MET amplification?   



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Onc San Antonio
Thank you Dr. @Tejas Patil for your insight, ...
Medical Oncologist at University of Colorado
I would get FISH based testing unless your NGS ass...
Medical Oncologist at New York Methodist Hosp
I have seen responses with increasing osimertinib ...
Medical Oncologist at Onc San Antonio
Thank you for your valuable input. 
Medical Oncologist at ProMedica Flower Hospital
@Tejas Patil, I have a patient with oligoprogressi...
Medical Oncologist at University of Colorado
Is the liver lesion within the radiation field whe...
Medical Oncologist at ProMedica Flower Hospital
The new progressive lesion has been treated with S...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more